noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

Business and Economy > Finance > Financial Markets

related tags Security Markets Stock Brokerage Forbes Global 2000 Financial Market Operators and Service Providers

Results Financial Markets

Kyverna Therapeutics Inc.

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Securities Fraud Lawsuit

-3h 18m
Bioage Labs Inc.

BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

-8h 5m
Kyverna Therapeutics Inc.

KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX

-19h 4m
Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

-23h 20m
Crinetics Pharmaceuticals Inc.

Crinetics Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

-23h 59m
Alpha Modus Holdings Inc.

Failure to Satisfy Listing Rule Form 8 K

yesterday
Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

yesterday
Neuroone Medical Technologies Corporation

Failure to Satisfy Listing Rule Form 8 K

yesterday
Axogen Inc.

Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

yesterday
Xilio Therapeutics Inc.

Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

yesterday